INTECH Investment Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Buy
2,687
+284
+12% +$25.9K ﹤0.01% 1663
2026
Q1
$231K Sell
2,403
-717
-23% -$71.7K ﹤0.01% 1683
2025
Q4
$304K Sell
3,120
-646
-17% -$55.4K ﹤0.01% 1760
2025
Q3
$268K Buy
3,766
+90
+2% +$6K ﹤0.01% 1896
2025
Q2
$220K Sell
3,676
-745
-17% -$40.8K ﹤0.01% 2040
2025
Q1
$232K Buy
+4,421
New +$248K ﹤0.01% 2012

Other funds holding IRMD

INTECH Investment Management's IRMD Position: Q2 2026 in Review

INTECH Investment Management increased its iRadimed (IRMD) stake by 12% in Q2 2026, buying an estimated $25.9K and bringing the position to 2,687 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

INTECH Investment Management first reported a position in IRMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $304K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • INTECH Investment Management held 2,687 shares of iRadimed worth $257K as of Q2 2026.
  • INTECH Investment Management bought 284 iRadimed shares in Q2 2026, an estimated $25.9K.
  • iRadimed made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1663 holding.
  • INTECH Investment Management first reported a position in iRadimed in Q1 2025 and has held it in 6 quarters since.
  • INTECH Investment Management's iRadimed position peaked at $304K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.